Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Complement factor B (Homo sapiens (Human)) | BDBM160506 (US10093663, Example 40 | US9682968, Example-40) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.0600 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis AG US Patent | Assay Description CVF-Bb complex prepared from purified cobra venom factor (1 μM), recombinant human complement factor B (expressed in drosophila cells and purifi... | US Patent US9682968 (2017) BindingDB Entry DOI: 10.7270/Q2XG9P9J | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Complement factor B (Homo sapiens (Human)) | BDBM160506 (US10093663, Example 40 | US9682968, Example-40) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 55 | n/a | n/a | n/a | n/a | 7.4 | 25 |
Novartis AG US Patent | Assay Description CVF-Bb complex prepared from purified cobra venom factor (1 μM), recombinant human complement factor B (expressed in drosophila cells and purifi... | US Patent US10093663 (2018) BindingDB Entry DOI: 10.7270/Q2DF6T75 | |||||||||||
More data for this Ligand-Target Pair |